Catalyst

Slingshot members are tracking this event:

Eisai has entered the generic pharmaceutical business in China through the acquisition of Liaoning TianYi Biological

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
EII.F

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 28, 2015
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Acquisition, China, Business License, Generic, Market